MORF

Eli Lilly completes acquisition of Morphic

PremiumThe Fly

3M ago

Morphic price target raised to $57 from $30 at Stifel

PremiumThe Fly

4M ago

Morphic downgraded to Hold from Buy at Jefferies

PremiumThe Fly

4M ago

Biotech Alert: Searches spiking for these stocks today

PremiumThe Fly

4M ago

BPMC

PremiumThe FlyMorphic downgraded to Hold from Buy at TD Cowen

5M ago

Morphic downgraded to Sector Perform from Outperform at RBC Capital

The Fly

Morphic downgraded to Sector Perform from Outperform at RBC Capital

5M ago

Morphic downgraded to Hold from Buy at Canaccord

The Fly

Morphic downgraded to Hold from Buy at Canaccord

5M ago

Morphic downgraded to Market Perform from Outperform at BMO Capital

PremiumThe Fly

5M ago

M&A News: Eli Lilly Snaps Up Morphic in $3.2B Deal

PremiumMarket News

5M ago

Eli Lilly to acquire Morphic for $57 per share

PremiumThe Fly

5M ago

Eli Lilly to acquire Morphic for $57 per share in cash

PremiumThe Fly

5M ago

PremiumThe FlyMorphic demonstrates real-time visual of small molecule alpha4beta7 inhibition

6M ago

Morphic Holding Launches New Stock Offering, Ends Previous Deal

Company Announcements

Morphic Holding Launches New Stock Offering, Ends Previous Deal

7M ago

Morphic files automatic mixed securities shelf

The Fly

Morphic files automatic mixed securities shelf

7M ago

Morphic reports Q1 EPS (91c), consensus (93c)

PremiumThe Fly

7M ago

Morphic appoints Cooper as Chief Medical Officer

PremiumThe Fly

8M ago

KROS

Morphic Holding Unveils Updated Corporate Presentation

PremiumCompany Announcements

8M ago

Morphic price target lowered to $66 from $68 at Canaccord

PremiumThe Fly

9M ago

PremiumThe FlyMorphic price target lowered to $64 from $67 at Wells Fargo

9M ago

Morphic reports FY23 revenue $521,000, consensus $500,000

The Fly

Morphic reports FY23 revenue $521,000, consensus $500,000

9M ago

Morphic initiated with bullish view at Citi, here’s why

The Fly

Morphic initiated with bullish view at Citi, here’s why

12M ago